Ursodeoxycholic acid in complex treatment of metabolic syndrome
Aim of investigation. Evaluation of effect of ursodeoxycholic acid (Ursosan) on levels of immunoreactive insulin, leptin, clinical and biochemical tests in metabolic syndrome.Material and methods. The group of patients with metabolic syndrome (66 patients, aged 38 to 67 years) received Ursosan withi...
Saved in:
Main Authors: | O. A. Tanchenko, S. V. Naryshkina, O. N. Sivyakova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2012-02-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1266 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Change of liver enzymes level during follow-up of patients exposed to vinylchloride
by: I. V. Kudayeva, et al.
Published: (2015-09-01) -
The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients
by: I. V. Mayev, et al.
Published: (2013-03-01) -
Association of leptin receptor Gln223Arg genetic polymorphism with obesity and non-alcoholic fatty liver disease
by: A. V. Morozova, et al.
Published: (2014-09-01) -
Metabolic syndrome and pancreatic lesions
by: O. S. Shifrin, et al.
Published: (2013-05-01) -
Insulin resistance surrogates are associated with all-cause mortality and cardiovascular mortality in population with metabolic syndrome: a retrospective cohort study of NHANES
by: Jinhao Liao, et al.
Published: (2025-02-01)